We're watching
EVAX for a potential moonshot breakout following strong momentum, low float dynamics, and fundamental catalysts tied to their AI-powered cancer vaccine program.
Setup Summary:
Sector: Biotech / AI immunotherapy
Technical Picture (Daily + 15m):
Trade Levels:
Notes:
“We don’t chase hype – we ride structure.”
Setup Summary:
Sector: Biotech / AI immunotherapy
- Market Cap: ~$15M (micro float)
- News Catalyst: Q1 earnings beat + EVX-01 Phase 2 dosing
- Analyst Target: $13 avg → +450% potential
Technical Picture (Daily + 15m):
- Breakout over $2.20 zone with clean base
- RSI breakout from 65 → 80
- MACD crossover + rising volume
- EMA9 & EMA20 support structure
- Pre-market highs: $2.37 (watch for breakout + hold)
Trade Levels:
- Entry Trigger: Above $2.40 with confirmation
- TP1: $2.80
- TP2: $3.30
- SL: $2.15 (flag low)
- Optional Fibo Re-Entry: $2.25–$2.30 zone
Notes:
- Float under pressure = high squeeze potential
- Fundamentals align with technicals → this is what we hunt for
- Small size advised – this is a moonshot, not a base trade
“We don’t chase hype – we ride structure.”
Order cancelled
UPDATE on EVAXEntry level was never confirmed. Price showed early strength, but volume faded quickly.
TP1 was almost touched, but without a solid breakout, there was no reason to chase.
Setup invalidated → no trade taken.
Reminder: “Almost isn’t enough.” We only act on confirmation.
Back to watchlist – not off the radar, just off the plan for now.
— Daddy Djole
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.